These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 734354)

  • 1. Response to doxorubicin in hairy cell leukaemia.
    McCarthy D; Catovsky D
    Scand J Haematol; 1978 Nov; 21(5):445-7. PubMed ID: 734354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy of progressive hairy-cell leukaemia.
    Cold S; Brincker H
    Eur J Haematol; 1987 Mar; 38(3):251-5. PubMed ID: 3595814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hairy cell leukaemia with severe bone marrow insufficiency. Complete remission after chemotherapy in two patients (author's transl)].
    Marty M; Calvo F; Castaigne S; Flandrin G
    Nouv Presse Med; 1981 Oct; 10(36):2977-9. PubMed ID: 7290952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hairy cell leukemia-variant with cladribine.
    Tetreault SA; Robbins BA; Saven A
    Leuk Lymphoma; 1999 Oct; 35(3-4):347-54. PubMed ID: 10706459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hairy cell leukemia (leukemic reticuloendotheliosis) II. Chlorambucil therapy in postsplenectomy patients with progressive disease.
    Golomb HM; Mintz U
    Blood; 1979 Aug; 54(2):305-9. PubMed ID: 454839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy-induced remission in a patient with small cell carcinoma of the lung and hairy cell leukemia.
    Kuebler JP; Earhart R; Hafez GR
    Cancer; 1985 Jun; 55(12):2758-60. PubMed ID: 2986824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment.
    Bastie JN; Cazals-Hatem D; Daniel MT; D'Agay MF; Rabian C; Glaisner S; Noel-Walter MP; Dabout D; Flandrin G; Dombret H; Poisson D; Degos L; Castaigne S
    Leuk Lymphoma; 1999 Nov; 35(5-6):555-65. PubMed ID: 10609793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
    Rucińska M; Machaczka M; Załuska A; Skotnicki AB
    Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hairy cell leukemia responsive to chemotherapy with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD).
    Patten E; Gill DP; Weiss GB
    Cancer Treat Rep; 1983 Dec; 67(12):1147-8. PubMed ID: 6197166
    [No Abstract]   [Full Text] [Related]  

  • 10. Unusual response of lymphocytic lymphoma (not hairy cell leukaemia) to splenectomy without chemotherapy.
    Jacobs P; King HS; Dent DM; Hayes M
    S Afr Med J; 1984 Apr; 65(17):687-9. PubMed ID: 6609443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hairy cell leukemia with alternating cycles of pentostatin and recombinant leukocyte A interferon: results of a phase II study.
    Martin A; Nerenstone S; Urba WJ; Longo DL; Lawrence JB; Clark JW; Hawkins MJ; Creekmore SP; Smith JW; Steis RG
    J Clin Oncol; 1990 Apr; 8(4):721-30. PubMed ID: 2313337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trials of pentostatin (Nipent) in hairy cell leukemia.
    Kraut EH
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):27-31. PubMed ID: 10877048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Massive retroperitoneal lymphadenopathy as a terminal event in hairy cell leukaemia.
    Mehta AB; Catovsky D; O'Brien CJ; Lott M; Bowley N; Hemmingway A
    Clin Lab Haematol; 1983; 5(3):259-63. PubMed ID: 6360496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of interferon in the treatment of hairy cell leukemia.
    Ratain MJ; Vardiman JW; Golomb HM
    Semin Oncol; 1986 Sep; 13(3 Suppl 2):21-8. PubMed ID: 3532332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aplastic anemia terminating in hairy cell leukemia. A report of two cases.
    Krause JR
    Cancer; 1984 Apr; 53(7):1533-7. PubMed ID: 6697293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis and therapy in hairy cell leukemia.
    Jansen J; den Ottolander GJ; Holdrinet RS; Tricot GJ; Hermans J
    Semin Oncol; 1984 Dec; 11(4 Suppl 2):472-8. PubMed ID: 6548834
    [No Abstract]   [Full Text] [Related]  

  • 17. [Classic Hodgkin's lymphoma in post-treatment hairy cell leukemia: report of a case].
    Chen DB; Shen DH
    Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):848-9. PubMed ID: 22336215
    [No Abstract]   [Full Text] [Related]  

  • 18. Hairy cell leukaemia: the role of alpha interferon.
    Platanias LC; Ratain MJ
    Eur J Cancer; 1991; 27 Suppl 4():S53-7. PubMed ID: 1799481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined treatment with splenectomy and cladribine in hairy cell leukemia in Taiwan: a clinicopathologic study of 5 cases.
    Yu YB; Li CY; Chen CC; You JY; Chau WK; Hsu HC; Gau JP; Chen PM; Ho CH
    J Chin Med Assoc; 2007 Dec; 70(12):551-5. PubMed ID: 18194897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hairy cell leukemia successfully treated with 2'-deoxycoformycin following refractoriness to splenectomy and alpha-interferon therapy].
    Shibata T; Hotta T
    Rinsho Ketsueki; 1992 Feb; 33(2):216-20. PubMed ID: 1635172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.